Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria, 1140
Location status: Recruiting
Location contact
Johannes Zeilinger, MD
CONTACT
Manuel Ruiss, Mac
CONTACT
NCT Number: NCT06607848
Intra-individual comparison of the PureSee EDOF IOL with the Acunex Vario EDOF IOL set for emmetropia.
Interested in participating?
Request Info21 year–105 year
All sexes
Interventional
Not applicable
Vienna, Austria, 1140
Location status: Recruiting
Johannes Zeilinger, MD
CONTACT
Manuel Ruiss, Mac
CONTACT
Spectacle-independence is a growing goal in modern cataract surgery. The procedure has evolved from a simple restoration of vision to a presbyopia correction approach. Although bilateral monofocal IOL implantation with the goal of emmetropia results in high patient satisfaction for distance vision, spectacle-dependence for reading and intermediate vision tasks is the usual outcome.
Enhanced Depth of Focus (EDOF) lenses have been on the market for some time to minimize this spectacle-dependency in intermediate tasks (computer work, dashboard, etc.). These IOLs have an extended distance focal range that extends into the intermediate distance, providing high quality vision over a continuous focal range, rather than single foci with blurring in between. The risk to the patient is comparable to that of all other monofocal systems, which generally have high patient satisfaction. The benefit of this study should be continuous sharp binocular vision at distance, intermediate (66 cm) and even near (40 cm). Another expected effect is the reduction of dysphotopic phenomena compared to other EDOF lenses.
The aim of this study is to compare the visual performance of two refractive EDOF lenses, namely the Acunex Vario with the Puresee IOL, in an intraindividual comparative study design. In order to achieve a satisfactory result, we planned to include 40 patients scheduled for cataract surgery in the study.
The examinations will all take place one week before, 1 week and 4-6 months after the operation. These include a visual acuity check at the three distances mentioned, slit lamp examination, pressure control, biometry, pupil width, defocus curve, quality of vision questionnaires, contrast sensitivity, halo&glare, optical coherence tomography, fundus examination, aberrometry and keratometry.
The main parameter to be examined is the distance-corrected visual acuity for the intermediate distance (66 cm) between the two IOLs at the follow-up examination after 4-6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Acunex Vario AN6V
PureSee EDOF IOL
Time frame: 6 months
Distance corrected visual acuity for intermediate distance given in logMAR will be measured at 66 cm using ETDRS charts
Time frame: 6 months
Uncorrected visual acuity for intermediate distance given in logMAR will be measured at 66 cm using ETDRS charts
Time frame: 6 months
Uncorrected and distance corrected visual acuity for far distance given in logMAR will be measured at 4 m using ETDRS charts
Time frame: 6 months
Uncorrected and distance corrected visual acuity for near distance given in logMAR will be measured at 40 cm using ETDRS charts
Time frame: 6 months
Monocular defocus curves will be assessed in logMAR at 4 m using an ETDRS chart
Time frame: 6 months
Potential halos will be assessed using the Aston Halometer App provided on a Tablet at 2 m
Time frame: 6 months
Contrast sensitivity will be tested using the Optec device
Time frame: 6 months
Dysphotopsia will be subjectively rated by the patients using a questionnaire and a visual analogue scale
Contact information is provided by the study sponsor or research team.
Johannes Zeilinger, MD
CONTACT
Manuel Ruiss, MSc
CONTACT
Vienna Institute for Research in Ocular Surgery
Other
Intraindividual Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses Set for Emmetropia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07468409
Cataract, Eye Diseases
Makati City, National Capital Region, Philippines
View Trial DetailsNCT07610226
Cataract, Eye Diseases
Greensboro, North Carolina, United States
View Trial DetailsNCT07715591
Anxiety Disorders, Behavior
Los Angeles, California, United States
View Trial DetailsNCT07471295
Cataract, Eye Diseases
Prague, Czechia
View Trial Details